In separate clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...

There’s an ongoing uncertainty among experts about whether neoadjuvant therapy or surgery first is best for patients with ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

Changing the standard sequence of treatment for operable pancreatic cancer could improve survival for some patients, say researchers. Some patients with operable disease and elevated levels of the CA ...

Harmful bacteria and fungi living in your mouth could triple your risk of developing pancreatic cancer, a new study has suggested. Experts have long believed that people with poor oral hygiene are ...

Distress as a predictor of mortality risk: A cohort analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care Symposium. This abstract does not include a full text component.

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Unlike organs like the liver or the heart, the pancreas plays a more subtle yet important role in a wide ...